JERUSALEM, Israel, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that patient recruitment in its multicenter clinical trial for major depression was completed in November 2011. The projected number of patients for the trial is 225. The Company noted that the actual number of patients may exceed this figure slightly.
